2014
DOI: 10.1007/s10482-014-0291-4
|View full text |Cite
|
Sign up to set email alerts
|

Microbial ketonization of ginsenosides F1 and C–K by Lactobacillus brevis

Abstract: Ginsenosides are the major pharmacological components in ginseng. We isolated lactic acid bacteria from Kimchi to identify microbial modifications of ginsenosides. Phylogenetic analysis of 16S rRNA gene sequences indicated that the strain DCY65-1 belongs to the genus Lactobacillus and is most closely related to Lactobacillus brevis. On the basis of TLC and HPLC analysis, we found two metabolic pathways: F1 → 6α,12β-dihydroxydammar-3-one-20(S)-O-β-D-glucopyranoside and C-K → 12β-hydroxydammar-3-one-20(S)-O-β-D-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 17 publications
0
16
0
Order By: Relevance
“…The ginsenoside content was not significantly different, whereas the content of ginsenoside metabolites was three times higher in FRG (14,914.3 μg/mL). The content of ginsenoside metabolites such as Rg3, Rg5, and Rk1; compounds K, Rh1, F2, and Rg2 [ 43 ]; and flavonoid content were increased as a result of fermentation. The activity of tyrosinase inhibitory (IC50) in the bioferment was 27.63 μg/mL and was also stronger than in RG (34.14 μg/mL).…”
Section: Overview Of Biofermentsmentioning
confidence: 99%
“…The ginsenoside content was not significantly different, whereas the content of ginsenoside metabolites was three times higher in FRG (14,914.3 μg/mL). The content of ginsenoside metabolites such as Rg3, Rg5, and Rk1; compounds K, Rh1, F2, and Rg2 [ 43 ]; and flavonoid content were increased as a result of fermentation. The activity of tyrosinase inhibitory (IC50) in the bioferment was 27.63 μg/mL and was also stronger than in RG (34.14 μg/mL).…”
Section: Overview Of Biofermentsmentioning
confidence: 99%
“…The ginsenoside content was not significantly different, whereas the content of ginsenoside metabolites was three times higher in FRG (14,914.3 μg/mL). The content of ginsenoside metabolites, like Rg3, Rg5, Rk1, compounds: K, Rh1, F2, Rg2 [44], and flavonoid content were increased as a result of fermentation. The activity of tyrosinase inhibitory (IC50) in the bioferment was 27.63 μg/mL and was also stronger than in RG (34.14 μg/mL).…”
Section: Ginsengmentioning
confidence: 99%
“…Thus, compound 10 was assigned as 3-O-β-D-glucopyranosyl-(1 → 2)-β-D-glucopyranosyl-3β,12β,20(S)-trihydroxydammar-24-ene-20-O-α-L-rhamnopyranosyl, which was first isolated from the Vietnamese ginseng and named vina-ginsenoside R17. 12 The other known substances were identified as 3-oxo-20(S) ginsenoside-Rh1 (2), 13 2β-hydroxydammar-3-one-20(S)-O-β-Dglucopyranoside (3), 14 chikusetsusaponin Fk2 (4), 15 5,6-didehydroginsenoside Rb1 (5), 16 gypenoside LXXV (6), 17 chikusetsusaponin VI (7), 18 19 ginsenoside Rb1 (12), 10 ginsenoside Rh1 (13), 20 ginsenoside CK (14) 21 and ginsenoside Rd (15). 11 .…”
Section: Papermentioning
confidence: 99%